This website uses cookies. By continuing you are agreeing to our privacy policy.

Maria Cortez, Ph.D.

headshot of Maria Cortez
University of Texas M.D. Anderson Cancer Center
Funded by LUNG FORCE
Overcoming Lung Cancer Immunotherapy Resistance

New treatments that harness the immune system to fight lung cancer (called immunotherapy) have shown exciting results. However, most patients do not respond to this therapy, and even those who do often develop disease progression. To find out why this occurs, our lab developed a mouse model of lung cancer resistant immunotherapy. We will build on our preliminary findings on changes in the metabolism of lipids (fats) in resistant tumors, and explore how these changes influence the ability of tumor cells to evade the immune system. We will then identify new targets that can be used to overcome immunotherapy resistance or as biomarkers that can help identify, before treatment, which patients will respond to these drugs.

Update: We identified inflammatory pathways that promote resistance to immunotherapy for lung cancer. We previously found that specific inflammatory pathways and small RNAs, known as microRNAs, are related to response to lung cancer immunotherapy. This year, we explored how these molecules influence the ability of tumor cells to evade the immune system. Our study has the potential to reveal new lipid-related targets for drug development or new treatments that combine inhibitors of these targets with immunotherapy for lung cancer.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.